Status | Study |
Recruiting |
Study Name: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002 Condition: Indolent Systemic Mastocytosis Date: 2016-06-16 Interventions: Drug: AK002 |
Recruiting |
Study Name: Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations Condition: Urticaria Pigmentosa Cutaneous Mastocytosis Date: 2016-03-15 Interventions: Other: skin biopsy A skin biop |
Recruiting |
Study Name: Mast Cell Connect: A Registry for Patients With Mastocytosis Condition: Mastocytosis Date: 2015-11-19 |
Completed |
Study Name: Treatment of Indolent Systemic Mastocytosis With PA101 Condition: Mastocytosis Systemic Mastocytosis Date: 2015-06-19 Interventions: Drug: PA101 40 mg PA101 admini |
Recruiting |
Study Name: Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis Condition: Systemic Mastocytosis Date: 2015-05-05 Interventions: Procedure: Mastocytosis diagnosis Some samples will be extracted from bone marrow aspirate and periphera |
Recruiting |
Study Name: Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis Condition: Aggressive Systemic Mastocytosis Mast Cell Leukemia Date: 2015-03-24 Interventions: Drug: Ibrutinib Given PO |
Completed |
Study Name: Midostaurin in Indolent Systemic Mastocytosis Condition: Indolent Systemic Mastocytosis Date: 2013-08-07 Interventions: Drug: Midostaurin, Midostaurin, twice daily 100 mg orally, continuously for 6 months |
Terminated |
Study Name: Cromoglicate in Mastocytosis Condition: Mastocytosis Date: 2012-07-11 Interventions: Drug: Cromoglicate Twice daily |
Recruiting |
Study Name: Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis Condition: Systemic Mastocytosis Date: 2012-05-16 Interventions: Drug: Cladribine and pegylated interpheron alpha-2a Cladri |
Completed |
Study Name: Study on Mastocytosis for Rupatadine Treatment Condition: Mastocytosis Date: 2011-11-23 Interventions: Drug: Rupatadin 20 mg, 28 days over 60 days Other Na |